Advisers to the US Food and Drug Administration on Tuesday voted overwhelmingly to recommend that the agency authorize Novavax’s COVID-19 vaccine for use in adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics. The panel of outside vaccine experts voted 21-0 with one abstention in favor of the vaccine for those 18 and …
Read More »NOVAVAX COVID VACCINE OVERWHELMINGLY BACKED BY US FDA PANEL
June 8, 2022